SCHEMBL259014

SCHEMBL259014

O=C(O)N1CCCCCC1=O.[Co]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.46
MITF O75030 1/20 0.46
KMT2A Q03164 3/20 0.42
ALDH1A1 P00352 4/20 0.38
MAPT P10636 3/20 0.38
HSD17B10 Q99714 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KDM4E B2RXH2 3/20 0.38
BLM P54132 2/20 0.38
MEN1 O00255 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
THRB P10828 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
RECQL P46063 1/20 0.38
TP53 P04637 2/20 0.37
STAT6 P42226 1/20 0.37
GAA P10253 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4059818 0.98 LMNA (0.52) LMNASMN1; SMN2MITFKMT2AALDH1A1
SCHEMBL4062492 0.98 LMNA (0.52) LMNASMN1; SMN2MITFKMT2AALDH1A1
SCHEMBL1238335 0.96 LMNA (0.54) LMNASMN1; SMN2MITFKMT2AALDH1A1
Hydrochloric Acid SCHEMBL11189351 0.93 LMNA (0.52) LMNASMN1; SMN2MITFKMT2AALDH1A1
SCHEMBL59155 0.89
SCHEMBL839318 0.86 LMNA (0.59) LMNASMN1; SMN2MITFKMT2AALDH1A1
SCHEMBL1700875 0.86 LMNA (0.59) LMNASMN1; SMN2MITFKMT2AALDH1A1
SCHEMBL10871994 0.86 LMNA (0.59) LMNASMN1; SMN2MITFKMT2AALDH1A1
SCHEMBL3620504 0.86 LMNA (0.59) LMNASMN1; SMN2MITFKMT2AALDH1A1
SCHEMBL2297517 0.86 LMNA (0.59) LMNASMN1; SMN2MITFKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8524643-B2 Surfactant mixtures for tertiary oil recovery BASF SE (DE) 2013-09-03 US disclosed
US-20120012311-A1 Surfactant Mixtures for Tertiary Oil Recovery BASF SE (DE) 2012-01-19 US disclosed
US-8053396-B2 recovering hydrocarbons from underground deposits by surfactant flooding ( surfactant and cosurfactant), cosurfactant containing amphiphilic polymer having one or more hydrophobic subunits based on a polyisobutene block, have terminally arranged double bonds, and hydrophilic subunits BASF SE (DE) 2011-11-08 US disclosed
US-7842302-B2 Mixture comprising a detergent and a co-detergent BASF SE (DE) 2010-11-30 US disclosed
US-7767748-B2 Aqueous polymer dispersions containing amphiphilic block copolymers, method for producing said dispersions and the use thereof BASF AKTIENGESELLSCHAFT (DE) 2010-08-03 US disclosed
US-7498386-B2 Derivatives of polymers for permanent modification of hydrophobic polymers BASF SE (DE) 2009-03-03 US disclosed
US-20080242790-A1 Aqueous Polymer Dispersions Containing Amphiphilic Block Copolymers, Method for Producing Said Dispersions and the Use Thereof BASF AKTIENGESELLSCHAFT (DE) 2008-10-02 US disclosed
US-20080199420-A1 Cosmetic oil in water emulsion ofamphiphilic polymer with hydrophilic and hydrophobic units formed from polyisobutenes modified with terminal polar groups, emulsifier, oil and water; ethylene oxide-propylene oxide block polymer modified polyisobutenyl succinic anhydride; hydroxylation, epoxidation BASF AKTIENGESELLSCHAFT (DE) 2008-08-21 US disclosed
US-20080194435-A1 Surfactant Mixtures For Tertiary Oil Recovery BASF AKTIENGESELLSCHAFT (DE) 2008-08-14 US disclosed
US-20070178056-A1 Mixture comprising a detergent and a co-detergent BASF AKTIENGESELLSCHAFT (DE) 2007-08-02 US disclosed
US-7173138-B2 Ligands for pnicogen chelate complexes with a metal of subgroup VIII and use of the complexes as catalysts for hydroformylation, carbonylation, hydrocyanation or hydrogenation BASF AKTIENGESELLSCHAFT (DE) 2007-02-06 US disclosed
US-20060106173-A1 Polymeric derivatives for permanently modifying hydrophobic polymers BASF AKTIENGESELLSCHAFT (DE) 2006-05-18 US disclosed
US-20040110960-A1 Ligands for pnicogen chelate complexes with a metal of subgroup VIII and use of the complexes as catalysts for hydroformylation, carbonylation, hydrocyanation or hydrogenation BASF AKTIENGESELLSCHAFT (DE) 2004-06-10 US disclosed
US-6639114-B2 Hydroformylation of unsaturated compounds catalyzed by a complex of a transition group VIII metal with a ligand which contains two phosphorus-containing groups that are bound to a molecular skeleton derived from bisphenol a BASF AKTIENGESELLSCHAFT (DE) 2003-10-28 US disclosed
US-6559344-B2 Hydroformylation BASF AKTIENGESELLSCHAFT (DE) 2003-05-06 US disclosed
US-6486359-B1 Catalyst comprising a complex of a metal of subgroup viii based on a phosphinite ligand, and a method for hydroformylation BASF AKTIENGESELLSCHAFT (DE) 2002-11-26 US disclosed
US-20020115892-A1 Of ethylenically unsaturated compounds using at least one complex or compound of a metal of transition group VIII with at least one bidentate phosphine ligand as hydroformylation catalyst BASF AKTIENGESELLSCHAFT (DE) 2002-08-22 US disclosed
US-20020111517-A1 Hydroformylation catalyst comprising a complex with ligands having a structure derived from bisphenol A BASF AKTIENGESELLSCHAFT (DE) 2002-08-15 US disclosed
US-6020441-A USING MIXTURE OF CARBON MONOXIDE AND HYDROGEN IN AQUEOUS DISPERSION BASF AKTIENGESELLSCHAFT (DE) 2000-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020115892-A1 Of ethylenically unsaturated compounds using at least one complex or compound of a metal of transition group VIII with at least one bidentate phosphine ligand as hydroformylation catalyst ETFB, ETFA, ELOVL6 LMNA 2996/4885SMN1; SMN2 3343/4885MITF 3538/4885
US-20020111517-A1 Hydroformylation catalyst comprising a complex with ligands having a structure derived from bisphenol A ESR1, ESR2, CYP4A11 LMNA 1514/4885SMN1; SMN2 4829/4885MITF 2226/4885
US-20080199420-A1 Cosmetic oil in water emulsion ofamphiphilic polymer with hydrophilic and hydrophobic units formed from polyisobutenes modified with terminal polar groups, emulsifier, oil and water; ethylene oxide-propylene oxide block polymer modified polyisobutenyl succinic anhydride; hydroxylation, epoxidation HAO2, LRBA, POLB LMNA 1169/4885SMN1; SMN2 4003/4885MITF 227/4885
US-20070178056-A1 Mixture comprising a detergent and a co-detergent APOB, DAGLB, DDOST LMNA 710/4885SMN1; SMN2 3129/4885MITF 3224/4885
US-20040110960-A1 Ligands for pnicogen chelate complexes with a metal of subgroup VIII and use of the complexes as catalysts for hydroformylation, carbonylation, hydrocyanation or hydrogenation OGG1, HPD, HPGD LMNA 1996/4885SMN1; SMN2 3248/4885MITF 4071/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.